A preclinical gene therapy platform combining CRISPR/Cas9 gene editing with patient-derived 3D liver organoids and humanized mouse models to correct inborn metabolic liver disorders ex vivo and in vivo. Offers a less inv...
Stem cell technology leveraging human amnion epithelial cells (AEC) and their secreted mediators to reverse fibrosis in organs including intestinal tissue. Combines intact cells with paracrine factors (extracellular vesi...